/KASE, June 2, 2026/ – The consolidated financial statements of NIH "Baiterek" JSC (KASE ticker – BTRK) for 2025 and the auditor's report have been published.

According to the report of KPMG Audit LLP, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of NIH "Baiterek" JSC and its subsidiaries as of December 31, 2025, as well as their consolidated financial results and consolidated cash flows for the year ended on that date, in accordance with International Financial Reporting Standards (IFRS).

According to the audited data as of December 31, 2025 (in thous. tenge, unless otherwise stated):

---------------------------------------------------------------
                                           as of          as of
Indicator                               31.12.25       31.12.24
--------------------------------- -------------- --------------
Authorized capital                 1,568,038,962  1,521,238,962
Equity (capital deficit)           3,574,738,712  3,001,621,516
Total assets                      19,047,636,988 14,438,236,555
Total liabilities                 15,472,898,276 11,436,615,039
Net profit (net loss)                409,868,976    408,220,102
Book value of common share, tenge       2,293.49       1,985.61
ROA, %                                      2.15           2.83
ROE, %                                     11.47          13.60
---------------------------------------------------------------

The financial statements and report are published on – see more

[2026-06-02]